Glycoprotein inhibitors in patients on chronic anticoagulation: Safe enough or too much risk?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Thrombosis and Haemostasis

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH09-10-0694PMID 20062940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.

  2009cited by this paper
• Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

  2009cited by this paper
• Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty

  2009cited by this paper
• Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials.

  2009cited by this paper
• Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment?

  2009cited by this paper
• Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation

  2008cited by this paper
• Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding

  2008cited by this paper
• Pro: ‘Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions’

  2008cited by this paper
• Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.

  2008cited by this paper
• Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'

  2008cited by this paper
• Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment.

  2008cited by this paper
• Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

  2008cited by this paper
• Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.

  2008cited by this paper
• Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.

  2007cited by this paper
• Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.

  2007cited by this paper
• The risk of bleeding with warfarin: A systematic review and performance analysis of clinical prediction rules

  2007cited by this paper
• Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.

  2007cited by this paper
• Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors: Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative

  2006cited by this paper
• Guidelines for the Management of Patients With Atrial Fibrillation

  2006cited by this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC

  2006cited by this paper
• Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.

  2005influential reference
• Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel

  2004cited by this paper
• Platelet GPIIb-IIIa blockers.

  1999cited by this paper
• Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.

  1998cited by this paper

• Epidemiologie, Risikofaktoren und Risikostratifizierung venöser Thromboembolien (VTE) in Schwangerschaft und Wochenbett

  2017cites this paper
• Combined antiplatelet therapy and oral anticoagulation: is a balance between thromboembolism and bleeding possible?

  2011cites this paper
• Bibliography - Editors' selection of current world literature.

  2010cites this paper
• Atherosclerotic coronary artery disease

  2010cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2010cites this paper